# Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers

> **NCT02506023** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 2 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** Desmopressin

## Key facts

- **NCT ID:** NCT02506023
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2018-06-15
- **Final completion:** 2018-06-15
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2018-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02506023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02506023, "Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02506023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*